MedTech Strategist | MedTech's Most Trusted Source

What if your next big #medtech connection is waiting in Dublin? Registration is now open for #InnovationDublin 2026, April 28–30. Join global investors, executives, and start-ups for three days of strategy and high-value networking: bit.ly/4pRUP4p

The only database of its kind in #medtech is here. Pathways’ Document Depot tracks global medtech policy documents, guidance, and rules in one searchable hub. Stay on top of the #regulatory landscape: bit.ly/4snTlAw

MedTech Strategist welcomes @EarlybirdVC as a Gold Sponsor of #InnovationDublin 2026. With €1B+ under management and decades of investing success, Earlybird supports the next generation of tech innovators: bit.ly/4sezofH #medtech

Will CMS reshape the #diabetes device market? Competitive bidding for CGMs and insulin pumps begins in 2028, bringing pricing pressure but potentially expanding patient access as the CGM market surpasses $13.8B globally: bit.ly/40yLX9l #medtech

Reimbursement can make or break a #medtech innovation. @bostonsci's Intracept has grown to ~$200M in revenue with coverage for 200M+ lives. See how a targeted #reimbursement strategy drove adoption: bit.ly/4sc2Qmp

Avalanche Medical B.V. and CEO Eric Meeder join #InnovationDublin 2026. Their SyCap implant treats focal cartilage defects and aims to delay knee replacement while preserving joint function: bit.ly/4dkRckv

AI is reshaping #medtech. But innovation must meet real-world adoption. Keynotes from Peter Fitzgerald (@Stanford) and Lee Fleisher (Rubrum Advising) at #InnovationDublin 2026 will explore what comes next: bit.ly/3P9cojA

MedTech Strategist welcomes SMARTSHAPE-project and Commercial Lead Ciarán Duffy as a presenting company at #InnovationDublin 2026. The Galway startup is advancing continuous #bloodpressure monitoring for improved hypertension care. Join us: bit.ly/3P9cojA

@HealthTechJess Absolutely. Deal activity is only part of the story.

@MedTechStrat Portfolio reshuffling makes headlines, but outcomes are what matter. The real question is whether these deals translate into meaningful patient benefits or just financial engineering.

Medtech M&A may be gearing up for a comeback. PwC reports 2025 deal value reached $97.6B, the highest in a decade, despite lower deal volume. Analysts expect renewed activity in 2026 as strategics reshape portfolios: bit.ly/4ux0oZo #medtech

What do FDA staffing cuts mean for #medtech innovation? Josh Makower (@joshatstanford) discusses #regulatory slowdowns, the US “first mover disadvantage,” and ways to improve efficiency in device review: bit.ly/4bpVggJ

MedTech Strategist welcomes @NAMSA_CRO as a Platinum Sponsor at #InnovationDublin 2026. A global CRO accelerating medical device development since 1967. Join us in Dublin: bit.ly/3NF1XUo

MedTech Strategist welcomes @Aspivix_Health and CEO Mathieu Horras as a presenting company at #InnovationDublin 2026. Their device carevix® aims to modernize #gynecology with gentler care: bit.ly/3NF1XUo

What if #emphysema treatment didn’t require sacrificing lung tissue? Apreo Health’s BREATHE Airway Scaffold helps release trapped air and restore breathing with a lung-preserving approach: bit.ly/474j7kW #medtech

We’re honored to welcome @MedmarcIns as a Platinum Sponsor of #InnovationDublin 2026. Thank you for supporting innovation in #medicaltechnology. Join us in Dublin: bit.ly/4bkf70U

How could pulsed field ablation change surgical AF treatment? This infographic shows Pulse Biosciences’ nPulse clamp, designed to create deep ablation lesions in about 2.5 seconds using nanosecond PFA: bit.ly/4baLdgX #medtech

China’s device approvals ticked up in 2025, with domestic and localized firms continuing to dominate. The total number of #devices approved in China increased slightly last year as the volume of products leveraging the special Innovative Device Pathway continues to grow.

How exposed are #diabetes device makers to Medicare competitive bidding? New CMS rules for CGMs and pumps could pressure pricing, but analysts expect limited revenue impact. See the projected 2028 exposure: bit.ly/4upyhLK

What if vascular grafts could reduce thrombosis and degeneration? Pittsburgh-based PECA Labs is developing polymer cardiovascular implants for pediatric and adult patients. Learn more about its platform of next-gen #medicaldevices: bit.ly/4ruORHf

Diagnostics may finally be having its moment. 2025 saw a record $60.2B in #diagnostics mega-deal M&A activity, signaling renewed investor confidence and momentum for tech-enabled diagnostic companies: bit.ly/4ukGX65

Where is #medtech capital coming from today? Join our #InnovationDublin 2026 panel on public, private, and patient capital featuring leaders from IHI, Anthro Ventures, @ClaretCapital, Goodbody, @Market_Pathways, and more: bit.ly/4s232o9